A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)

NCT06860243 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Healthy Participants

Interventions

DRUG: Opevesostat
DRUG: Prednisone
DRUG: Fludrocortisone acetate

Sponsor

Merck Sharp & Dohme LLC